DOI QR코드

DOI QR Code

Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions

  • Irfan, Muhammad (Laboratory of Veterinary Physiology and Cell Signaling, College of Veterinary Medicine, Kyungpook National University) ;
  • Kwak, Yi-Seong (R&D Headquarters, Korean Ginseng cooperation) ;
  • Han, Chang-Kyun (R&D Headquarters, Korean Ginseng cooperation) ;
  • Hyun, Sun Hee (R&D Headquarters, Korean Ginseng cooperation) ;
  • Rhee, Man Hee (Laboratory of Veterinary Physiology and Cell Signaling, College of Veterinary Medicine, Kyungpook National University)
  • Received : 2020.02.24
  • Accepted : 2020.03.02
  • Published : 2020.07.15

Abstract

Cardiovascular diseases are a rapidly growing epidemic with high morbidity and mortality. There is an urgent need to develop nutraceutical-based therapy with minimum side effects to reduce cardiovascular risk. Panax ginseng occupies a prominent status in herbal medicine for its various therapeutic effects against inflammation, allergy, diabetes, cardiovascular diseases, and even cancer, with positive, beneficial, and restorative effects. The active components found in most P. ginseng varieties are known to include ginsenosides, polysaccharides, peptides, alkaloids, polyacetylene, and phenolic compounds, which are considered to be the main pharmacologically active constituents in ginseng. P. ginseng is an adaptogen. That is, it supports living organisms to maintain optimal homeostasis by exerting effects that counteract physiological changes caused by physical, chemical, or biological stressors. P. ginseng possesses immunomodulatory (including both immunostimulatory and immunosuppressive), neuromodulatory, and cardioprotective effects; suppresses anxiety; and balances vascular tone. P. ginseng has an antihypertensive effect that has been explained by its vasorelaxant action, and paradoxically, it is also known to increase blood pressure by vasoconstriction and help maintain cardiovascular health. Here, we discuss the potential adaptogenic effects of P. ginseng on the cardiovascular system and outline a future research perspective in this area.

Keywords

References

  1. Brekhman I, Dardymov I. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969;9(1):419-30. https://doi.org/10.1146/annurev.pa.09.040169.002223
  2. Winston D. Adaptogens: herbs for strength, stamina, and stress relief. Simon and Schuster; 2019.
  3. Panossian AG. Adaptogens: tonic herbs for fatigue and stress. Alternative Compl Ther 2003;9(6):327-31. https://doi.org/10.1089/107628003322658610
  4. Winston D. Harmony remedies: an overview of adaptogens. Washington, NJ: Herbal Therapeutics Research Library; 2004.
  5. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, et al. Heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation 2016;133(4). e38-360. https://doi.org/10.1161/CIR.0000000000000350
  6. Pagidipati NJ, Gaziano TA. Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation 2013;127(6):749-56. https://doi.org/10.1161/CIRCULATIONAHA.112.128413
  7. Shafiq G, Tatinati S, Ang WT, Veluvolu KC. Automatic identification of systolic time intervals in seismocardiogram. Sci Rep 2016;6:37524. https://doi.org/10.1038/srep37524
  8. Gielen S, Landmesser U. The year in cardiology 2013: cardiovascular disease prevention. Eur Heart J 2014;35(5):307-12. https://doi.org/10.1093/eurheartj/eht551
  9. Lim KH, Ko D, Kim J-H. Cardioprotective potential of Korean Red Ginseng extract on isoproterenol-induced cardiac injury in rats. J Ginseng Res 2013;37(3):273. https://doi.org/10.5142/jgr.2013.37.273
  10. Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med: JABFM 2015;28(2):283-93. https://doi.org/10.3122/jabfm.2015.02.140189
  11. Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res 2004;114(5-6):447-53. https://doi.org/10.1016/j.thromres.2004.07.020
  12. Donner L, Gremer L, Ziehm T, Gertzen CGW, Gohlke H, Willbold D, Elvers M. Relevance of N-terminal residues for amyloid-beta binding to platelet integrin alphaIIbbeta3, integrin outside-in signaling and amyloid-beta fibril formation. Cell Signal 2018;50:121-30. https://doi.org/10.1016/j.cellsig.2018.06.015
  13. Gowert NS, Donner L, Chatterjee M, Eisele YS, Towhid ST, Munzer P, Walker B, Ogorek I, Borst O, Grandoch M, et al. Blood platelets in the progression of Alzheimer's disease. PloS One 2014;9(2). e90523. https://doi.org/10.1371/journal.pone.0090523
  14. Barrett NE, Holbrook L, Jones S, Kaiser WJ, Moraes LA, Rana R, Sage T, Stanley RG, Tucker KL, Wright B, et al. Future innovations in anti-platelet therapies. Br J Pharmacol 2008;154(5):918-39. https://doi.org/10.1038/bjp.2008.151
  15. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008;451(7181):914-8. https://doi.org/10.1038/nature06797
  16. Grimm Jr RH, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: treatment of Mild Hypertension Study (TOMHS). Hypertension 1997;29(1):8-14. https://doi.org/10.1161/01.hyp.29.1.8
  17. Badimon L, Vilahur G, Padro T. Nutraceuticals and atherosclerosis: human trials. Cardiovasc Therapeut 2010;28(4):202-15. https://doi.org/10.1111/j.1755-5922.2010.00189.x
  18. Kim J-H. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. J Ginseng Res 2018;42(3):264-9. https://doi.org/10.1016/j.jgr.2017.10.004
  19. Irfan M, Kim M, Rhee MH. Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases. J Ginseng Res 2020;44(1):24-32. https://doi.org/10.1016/j.jgr.2019.05.005
  20. Lee CH, Kim J-H. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 2014;38(3):161-6. https://doi.org/10.1016/j.jgr.2014.03.001
  21. Mohanan P, Subramaniyam S, Mathiyalagan R, Yang D-C. Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J Ginseng Res 2018;42(2):123-32. https://doi.org/10.1016/j.jgr.2017.01.008
  22. Fernandez-Moriano C, Gonzalez-Burgos E, Iglesias I, Lozano R, Gomez-Serranillos MP. Evaluation of the adaptogenic potential exerted by ginsenosides Rb1 and Rg1 against oxidative stress-mediated neurotoxicity in an in vitro neuronal model. PloS One 2017;12(8).
  23. Patel S, Rauf A. Adaptogenic herb ginseng (Panax) as medical food: status quo and future prospects. Biomed Pharmacother 2017;85:120-7. https://doi.org/10.1016/j.biopha.2016.11.112
  24. Nocerino E, Amato M, Izzo AA. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 2000;71:S1-5. https://doi.org/10.1016/S0367-326X(00)00170-2
  25. Shin W, Yoon J, Oh GT, Ryoo S. Korean red ginseng inhibits arginase and contributes to endotheliumdependent vasorelaxation through endothelial nitric oxide synthase coupling. J Ginseng Res 2013;37(1):64. https://doi.org/10.5142/jgr.2013.37.64
  26. Jeon BH, Kim CS, Park KS, Lee JW, Park JB, Kim K-J, Kim SH, Chang SJ, Nam KY. Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. Gen Pharmacol: Vasc Syst 2000;35(3):135-41. https://doi.org/10.1016/S0306-3623(01)00096-9
  27. Vuksan V, Sung M-K, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metabol Cardiovasc Dis 2008;18(1):46-56. https://doi.org/10.1016/j.numecd.2006.04.003
  28. Qin N, Gong Q-h, Wei L-w, Wu Q, Huang X-n. Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats. Biol Pharm Bull 2008;31(8):1530-5. https://doi.org/10.1248/bpb.31.1530
  29. Rhee M-Y, Kim Y-S, Bae J-H, Nah D-Y, Kim Y-K, Lee M-M, Kim HY. Effect of Korean red ginseng on arterial stiffness in subjects with hypertension. Journal Alternative Compl Med 2011;17(1):45-9. https://doi.org/10.1089/acm.2010.0065
  30. Kitagawa H, Iwaki R. Pharmacological study on panax ginseg. Nihon Yakurigaku Zasshi Folia Pharmacologica Japonica 1963;59:348-54. https://doi.org/10.1254/fpj.59.348
  31. Siegel RK. Ginseng abuse syndrome: problems with the panacea. Jama 1979;241(15):1614-5. https://doi.org/10.1001/jama.1979.03290410046024
  32. Chung CH, Hong SP, Cho SH, Hong JG, Lee YK, Lim GH, Yang WH, You HJ, Woo SC, Choi CH, et al. Influence of total ginseng saponin on contractile responses of vasoconstrictors in the isolated rat aorta. Kor Circ J 1999;29(9):976-84. https://doi.org/10.4070/kcj.1999.29.9.976
  33. Chen I-J, Chang M-Y, Chiao S-L, Chen J-L, Yu C-C, Yang S-H, Liu JM, Hung CC, Yang RC, Chang HC, et al. Korean red ginseng improves blood pressure stability in patients with intradialytic hypotension. Evid base Compl Alternative Med 2012;2012.
  34. Park D. Pressor and depressor actions of Panax Ginseng in mammals. Kor Med J 1960;5(85):98. 1960.
  35. Petkov W. Pharmacological studies of the drug Panax ginseng. Mitteilung Arzneim Forschung 1961;11(418):22. 1961.
  36. Wood WB, Roh BL, White RP. Cardiovascular actions of Panax ginseng in dogs. Jpn J Pharmacol 1964;14(3):284-94. https://doi.org/10.1254/jjp.14.284
  37. Effect of Korean red ginseng powder (GP), administered orally, on blood pressure in hypertensive rats. In: Sokabe H, Kishi K, Watanabe TX, editors. Proceedings of the ginseng society conference. The Korean Society of Ginseng; 1984.
  38. Kang SY, Schini-Kerth VB, Kim ND. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci 1995;56(19):1577-86. https://doi.org/10.1016/0024-3205(95)00124-O
  39. Kim ND, Kang SY, Schini VB. Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. Gen Pharmacol 1994;25(6):1071-7. https://doi.org/10.1016/0306-3623(94)90121-X
  40. Tousoulis D, Kampoli A-M, Tentolouris Nikolaos Papageorgiou C, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012;10(1):4-18. https://doi.org/10.2174/157016112798829760
  41. Hien TT, Kim ND, Pokharel YR, Oh SJ, Lee MY, Kang KW. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. Toxicol Appl Pharmacol 2010;246(3):171-83. https://doi.org/10.1016/j.taap.2010.05.008
  42. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407(6803):538-41. https://doi.org/10.1038/35035131
  43. Lau W-S, Chan RY-K, Guo D-A, Wong M-S. Ginsenoside Rg1 exerts estrogenlike activities via ligand-independent activation of $ER{\alpha}$ pathway. J Steroid Biochem Mol Biol 2008;108(1-2):64-71. https://doi.org/10.1016/j.jsbmb.2007.06.005
  44. Siegel RK. Ginseng and high blood pressure. Jama 1980;243(1):32. https://doi.org/10.1001/jama.1980.03300270020020
  45. Wang X, Chu S, Qian T, Chen J, Zhang J. Ginsenoside Rg1 improves male copulatory behavior via nitric oxide/cyclic guanosine monophosphate pathway. J of Sex Med 2010;7(2):743-50. https://doi.org/10.1111/j.1743-6109.2009.01482.x
  46. Abdel-Wahhab MA, Joubert O, El-Nekeety AA, Yoon W, Kim Y, Rihn B. Aphrodisiac effects of Panax ginseng extract standardized with ginsenoside Rg3 in male rats. Gen Health Med Sci 2014;1(1):3-8.
  47. De Andrade E, De Mesquita AA, de Almeida Claro J, De Andrade PM, Ortiz V, Paranhos M, Srougi M, Erdogrun T. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian J Androl 2007;9(2):241-4. https://doi.org/10.1111/j.1745-7262.2007.00210.x
  48. Kim T-H, Jeon SH, Hahn E-J, Paek K-Y, Park JK, Youn NY, Lee HL. Effects of tissue-cultured mountain ginseng (Panax ginseng CA Meyer) extract on male patients with erectile dysfunction. Asian J Androl 2009;11(3):356. https://doi.org/10.1038/aja.2008.32
  49. Toh H. Improved isolated heart contractility and mitochondrial oxidation after chronic treatment with Panax ginseng in rats. Am J Chin Med 1994;22:275-84. 03n04. https://doi.org/10.1142/S0192415X94000334
  50. Kong H-l, Wang J-p, Li Z-q, Zhao S-m, Dong J, Zhang W-w. Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo. Acta Pharmacol Sin 2009;30(4):396-403. https://doi.org/10.1038/aps.2009.2
  51. Wang YG, Zima AV, Ji X, Pabbidi R, Blatter LA, Lipsius SL. Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;295(2):H851-9. https://doi.org/10.1152/ajpheart.01242.2007
  52. Bai C-X, Sunami A, Namiki T, Sawanobori T, Furukawa T. Electrophysiological effects of ginseng and ginsenoside Re in Guinea pig ventricular myocytes. Eur J Pharmacol 2003;476(1-2):35-44. https://doi.org/10.1016/S0014-2999(03)02174-5
  53. Choi S-H, Shin T-J, Lee B-H, Chu D-h, Choe H, Pyo M-K, Hwang SH, Kim BR, Lee SM, Lee JH, et al. Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit. Eur J Pharmacol 2010;637(1-3):138-47. https://doi.org/10.1016/j.ejphar.2010.04.001
  54. Kim C-s, Son S-j, Kim H-s, Kim Y-d, Lee K-s, Jeon B-h, Kim KJ, Park JK, Park JB. Modulating effect of ginseng saponins on heterologously expressed HERG currents in Xenopus oocytes. Acta Pharmacol Sin 2005;26(5):551-8. https://doi.org/10.1111/j.1745-7254.2005.00116.x
  55. Jeong D, Irfan M, Kim S-D, Kim S, Oh J-H, Park C-K, Kim HK, Rhee MH. Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation. J Ginseng Res 2017;41(4):548-55. https://doi.org/10.1016/j.jgr.2016.11.003
  56. Irfan M, Jeong D, Kwon H-W, Shin J-H, Park S-J, Kwak D, Kim TH, Lee DH, Park HJ, Rhee MH. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling. Vasc Pharmacol 2018;109:45-55. https://doi.org/10.1016/j.vph.2018.06.002
  57. Irfan M, Jeong D, Saba E, Kwon H-W, Shin J-H, Jeon B-R, Kim S, Kim SD, Lee DH, Nah SY, et al. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling. Platelets 2019;30(5):589-98. https://doi.org/10.1080/09537104.2018.1479033
  58. Fan H-Y, Fu F-H, Yang M-Y, Xu H, Zhang A-H, Liu K. Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res 2010;126(1):e17-22. https://doi.org/10.1016/j.thromres.2010.04.006
  59. Cho YI, Cho DJ, Rosenson RS. Endothelial shear stress and blood viscosity in peripheral arterial disease. Curr Atheroscler Rep 2014;16(4):404. https://doi.org/10.1007/s11883-014-0404-6
  60. Endale M, Lee W, Kamruzzaman S, Kim S, Park J, Park M, Park TY, Park HJ, Cho JY, Rhee MH. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. Br J Pharmacol 2012;167(1):109-27. https://doi.org/10.1111/j.1476-5381.2012.01967.x
  61. Yamamoto M, Uemura T, Nakama S, Uemiya M, Kumagai A. Serum HDLcholesterol-increasing and fatty liver-improving actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect on hyperlipidemia in man. Am J Chin Med 1983;11(1-4):96-101. https://doi.org/10.1142/S0192415X83000161
  62. Hwang S-Y, Son DJ, Kim I-W, Kim D-M, Sohn S-H, Lee J-J, Kim SK. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res 2008;22(6):778-83. https://doi.org/10.1002/ptr.2363
  63. Saba E, Jeon BR, Jeong D-H, Lee K, Goo Y-K, Kim S-H, Sung CK, Roh SS, Kim SD, Kim HK, et al. Black ginseng extract ameliorates hypercholesterolemia in rats. J Ginseng Res 2016;40(2):160-8. https://doi.org/10.1016/j.jgr.2015.07.003
  64. Kwak Y-S, Kyung J-S, Kim JS, Cho JY, Rhee M-H. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biol Pharm Bull 2010;33(3):468-72. https://doi.org/10.1248/bpb.33.468
  65. In G, Ahn N-G, Bae B-S, Lee M-W, Park H-W, Jang KH, Cho BG, Han CK, Park CK, Kwak YS. In situ analysis of chemical components induced by steaming between fresh ginseng, steamed ginseng, and red ginseng. J Ginseng Res 2017;41(3):361-9. https://doi.org/10.1016/j.jgr.2016.07.004
  66. Laclaustra M, Corella D, Ordovas JM. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metabol Cardiovasc Dis 2007;17(2):125-39. https://doi.org/10.1016/j.numecd.2006.10.005
  67. Morrison CD, Huypens P, Stewart LK, Gettys TW. Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity. Biochim Biophys Acta (BBA)-Mol Basis Dis 2009;1792(5):409-16. https://doi.org/10.1016/j.bbadis.2008.09.005
  68. Venancio JC, Margatho LO, Rorato R, Rosales RRC, Debarba LK, Coletti R, Antunes-Rodrigues J, Elias CF, Elias LLK. Short-term high-fat diet increases leptin activation of CART neurons and advances puberty in female mice. Endocrinology 2017;158(11):3929-42. https://doi.org/10.1210/en.2017-00452
  69. Kwak Y-S, Kyung J-S, Wee J-J. Anti-obesity activity of red ginseng acidic polysaccharide from Korean red ginseng (Panax ginseng CA Meyer). Adv Complement Alt Med 2019;42(2):1-10.
  70. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148(3):293-300. https://doi.org/10.1530/eje.0.1480293
  71. Gowert NS, Donner L, Chatterjee M, Eisele YS, Towhid ST, Munzer P, Walker B, Ogorek I, Borst O, Grandoch M. Blood platelets in the progression of Alzheimer's disease. PloS One 2014;9(2).
  72. Casoli T, Balietti M, Giorgetti B, Solazzi M, Scarpino O, Fattoretti P. Platelets in Alzheimer's disease-associated cellular senescence and inflammation. Curr Pharmaceut Des 2013;19(9):1727-38.
  73. Shen MY, Hsiao G, Fong TH, Chen HM, Chou DS, Lin CH, Sheu JR, Hsu CY. Amyloid beta peptide-activated signal pathways in human platelets. Eur J Pharmacol 2008;588(2-3):259-66. https://doi.org/10.1016/j.ejphar.2008.04.040
  74. Kokjohn TA, Van Vickle GD, Maarouf CL, Kalback WM, Hunter JM, Daugs ID, Luehrs DC, Lopez J, Brune D, Sue LI, et al. Chemical characterization of proinflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. Biochim Biophys Acta (BBA)-Mol Basis Dis 2011;1812(11):1508-14. https://doi.org/10.1016/j.bbadis.2011.07.004
  75. Davies TA, Long HJ, Eisenhauer PB, Hastey R, Cribbs DH, Fine RE, Simons ER. ${\beta}$ amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system. Amyloid 2000;7(3):153-65. https://doi.org/10.3109/13506120009146830
  76. Lee S-T, Chu K, Sim J-Y, Heo J-H, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22(3):222-6. https://doi.org/10.1097/WAD.0b013e31816c92e6
  77. Wang Y, Liu J, Zhang Z, Bi P, Qi Z, Zhang C. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease. Neurosci Lett 2011;487(1):70-2. https://doi.org/10.1016/j.neulet.2010.09.076
  78. Ong W-Y, Farooqui T, Koh H-L, Farooqui AA, Ling E-A. Protective effects of ginseng on neurological disorders. Front Aging Neurosci 2015;7:129.
  79. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996;23(8):728-32. https://doi.org/10.1111/j.1440-1681.1996.tb01767.x
  80. Nag SA, Qin J, Wang W, Wang M-H, Wang H, Zhang R. Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front Pharmacol 2012;3:25. https://doi.org/10.3389/fphar.2012.00025
  81. Yang Q, Wang N, Zhang J, Chen G, Xu H, Meng Q, Du Y, Yang X, Fan H. In vitro and in silico evaluation of stereoselective effect of ginsenoside isomers on platelet P2Y12 receptor. Phytomedicine 2019;64:152899. https://doi.org/10.1016/j.phymed.2019.152899
  82. Azike CG, Charpentier PA, Hou J, Pei H, Lui EMK. The Yin and Yang actions of North American ginseng root in modulating the immune function of macrophages. Chin Med 2011;6(1):21. https://doi.org/10.1186/1749-8546-6-21

Cited by

  1. Panax ginseng callus, suspension, and root cultures: extraction and qualitative analysis vol.8, pp.2, 2020, https://doi.org/10.21603/2308-4057-2020-2-369-376
  2. Inhibition of angiotensin II-induced hypertrophy and cardiac dysfunction by North American ginseng (Panax quinquefolius) vol.99, pp.5, 2020, https://doi.org/10.1139/cjpp-2020-0480
  3. Network Pharmacology of Ginseng (Part II): The Differential Effects of Red Ginseng and Ginsenoside Rg5 in Cancer and Heart Diseases as Determined by Transcriptomics vol.14, pp.10, 2020, https://doi.org/10.3390/ph14101010
  4. Investigating the effect of microbial inoculants Frankia F1 on growth-promotion, rhizosphere soil physicochemical properties, and bacterial community of ginseng vol.172, 2020, https://doi.org/10.1016/j.apsoil.2021.104369